This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Ryoji Sekiyama: Innovator in Antibacterial Agents
Introduction
Ryoji Sekiyama is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of antimicrobial agents, particularly in the prevention and treatment of bacterial infections. His innovative work has the potential to impact healthcare positively.
Latest Patents
Ryoji Sekiyama holds a patent for an antimicrobial agent that effectively combats bacteria from multiple genera, including Streptococcus, Moraxella, Haemophilus, and Klebsiella. The invention combines a penicillin antibiotic, specifically amoxicillin, with a cephem antibiotic, such as cefixime or cefdinir. This antimicrobial agent can be administered as a mixed preparation or as individual preparations for combined administration.
Career Highlights
Ryoji Sekiyama is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His work in the field of antibiotics showcases his commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Ryoji Sekiyama has collaborated with esteemed colleagues, including Yoshimi Matsumoto and Shuichi Tawara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Ryoji Sekiyama's contributions to the development of antibacterial agents highlight his role as a significant inventor in the pharmaceutical industry. His innovative approach to combating bacterial infections demonstrates the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
